1. Home
  2. NTRA vs CHD Comparison

NTRA vs CHD Comparison

Compare NTRA & CHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • CHD
  • Stock Information
  • Founded
  • NTRA 2003
  • CHD 1846
  • Country
  • NTRA United States
  • CHD United States
  • Employees
  • NTRA N/A
  • CHD N/A
  • Industry
  • NTRA Medical Specialities
  • CHD Package Goods/Cosmetics
  • Sector
  • NTRA Health Care
  • CHD Consumer Discretionary
  • Exchange
  • NTRA Nasdaq
  • CHD Nasdaq
  • Market Cap
  • NTRA 27.0B
  • CHD 21.6B
  • IPO Year
  • NTRA 2015
  • CHD N/A
  • Fundamental
  • Price
  • NTRA $199.57
  • CHD $86.98
  • Analyst Decision
  • NTRA Strong Buy
  • CHD Hold
  • Analyst Count
  • NTRA 18
  • CHD 13
  • Target Price
  • NTRA $206.17
  • CHD $101.38
  • AVG Volume (30 Days)
  • NTRA 1.3M
  • CHD 2.3M
  • Earning Date
  • NTRA 11-06-2025
  • CHD 10-31-2025
  • Dividend Yield
  • NTRA N/A
  • CHD 1.36%
  • EPS Growth
  • NTRA N/A
  • CHD 42.14
  • EPS
  • NTRA N/A
  • CHD 3.17
  • Revenue
  • NTRA $2,116,676,000.00
  • CHD $6,141,000,000.00
  • Revenue This Year
  • NTRA $25.70
  • CHD $1.98
  • Revenue Next Year
  • NTRA $15.42
  • CHD $3.98
  • P/E Ratio
  • NTRA N/A
  • CHD $27.41
  • Revenue Growth
  • NTRA 38.17
  • CHD 1.45
  • 52 Week Low
  • NTRA $125.38
  • CHD $81.33
  • 52 Week High
  • NTRA $203.23
  • CHD $116.46
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 69.72
  • CHD 50.14
  • Support Level
  • NTRA $193.29
  • CHD $81.33
  • Resistance Level
  • NTRA $203.23
  • CHD $88.18
  • Average True Range (ATR)
  • NTRA 7.37
  • CHD 1.87
  • MACD
  • NTRA 0.25
  • CHD 0.31
  • Stochastic Oscillator
  • NTRA 80.29
  • CHD 67.21

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About CHD Church & Dwight Company Inc.

Church & Dwight is the leading global producer of baking soda. Its portfolio extends beyond its legacy category to include laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its brands also include Batiste, OxiClean, Vitafusion, Hero, and TheraBreath, which together with Arm & Hammer constitute around 70% of its annual sales and profits. Most recently, the firm added Touchland and its hand sanitizer business to its fold. Even as it works to expand its product reach, Church & Dwight still derives around 80% of its sales from its home market in the US.

Share on Social Networks: